South Texas Accelerated Research Therapeutics   Report issue

For profit Phase 1 Phase 2
Founded: San Antonio TX United States (2007)

Organization Overview

First Clinical Trial
2007
NCT00364676
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

South Texas Accelerated Research Therapeutics | South Texas Accelerated Research Therapeutics, LLC | South Texas Accelerated Research Therapeutics, LLC (START) | South Texas Accelerated Research Therapeutics (START) | START (South Texas Accelerated Research Therapeutics) | START- South Texas Accelerated Research Therapeutics, LLC

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hodgkin Disease (Phase 1)

Lymphoma (Phase 1)

Lymphoma, Non-Hodgkin (Phase 1)

Melanoma (Phase 1)

Neoplasms (Phase 2)

Prostatic Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 19
  • # of Trial APIs: 20